Wegovy after one month: what actually happens in week one to four

The biggest misconception about month one: you're not meant to have lost much yet

Most people starting Wegovy expect the first four weeks to deliver a noticeable drop on the scales. The reality is more measured. In month one, you are on 0.25 mg, the starting dose that exists specifically to let your body adjust, not to drive weight loss. The prescribing schedule set out in the NHS patient information for semaglutide moves through 0.25 mg and 0.5 mg before reaching 1.0 mg, 1.7 mg and eventually 2.4 mg (or up to the newer 7.2 mg pen, approved by the MHRA in April 2026). Each step takes roughly four weeks. That means week four is the very beginning of this process, not a meaningful checkpoint for results.

Let that expectation go. Month one is about your digestive system getting used to how semaglutide slows gastric emptying. Some people notice their appetite quietly drop. Others find the nausea dominates. Both responses are normal. The treatment is working even when the scales aren't moving much yet.

If you want a fuller picture of how the dose schedule and the overall treatment arc work, the Wegovy overview page covers both in detail.

What side effects tend to show up in weeks one to four

The first month carries the highest likelihood of gastrointestinal side effects, nausea, loose stools, constipation, burping, and a general feeling of fullness after small amounts of food. For most people these are mild to moderate and fade within days to two weeks as the body adjusts. Eating smaller portions, avoiding very fatty or spicy meals, and staying well hydrated all help.

Fatigue and mild headaches appear in some patients during the adjustment period too. Injection site reactions (a little redness or itching at the site) are possible with any subcutaneous pen; rotating between the abdomen, thigh and upper arm reduces them.

Pancreatitis is a rare but serious risk with GLP-1 medicines. The MHRA highlighted this in a Drug Safety Update in January 2026: if you develop severe stomach pain that spreads to your back, with or without vomiting, stop and seek urgent medical attention. Do not wait and see. For anything less urgent (persistent nausea that isn't settling, concerns about how you feel) contact your prescriber. At nume, our aftercare team is available seven days a week for exactly these conversations.

Questions about whether the side effects are worth pushing through, or whether to pause the dose, are common at month one. Your prescriber is the right person to guide that, based on your individual picture.

How much weight loss is realistic by the end of week four

In the STEP 1 trial published in the New England Journal of Medicine, participants on semaglutide 2.4 mg achieved an average weight reduction of around 15% over 68 weeks. That figure is for the full treatment period at the maintenance dose, not month one. Early in the trial, weight loss was gradual precisely because the dose was still building.

In practice, a loss of one to three kilograms by the end of the first month is a reasonable expectation for many people, though individual variation is wide. If you want to understand what those early weeks typically look like in more detail, our page on what to expect from Wegovy after one month walks through the experience honestly. Some see more, some see less, and some see very little change at all. That is not a signal the treatment is failing.

If you are curious about how results develop over a longer horizon, the picture at two months on Wegovy gives a clearer read once the dose has increased. For more on the cost side of a full course (useful context when planning ahead) the Wegovy cost page sets out what private treatment typically involves.

Should you consider stopping after one month?

This is a question our prescribers hear regularly, and the honest answer is: not without a clinical conversation first. Month one is the lowest dose, the highest side-effect burden, and the least representative of how the treatment will perform. Stopping at this point means missing the period where Wegovy is most likely to produce meaningful change.

That said, there are situations (medical reasons, a side effect that isn't settling, a change in circumstances) where pausing or stopping is the right call. The right approach is always to speak to your prescriber rather than just putting the pen down. If you are weighing up that decision, the page on stopping Wegovy after one month goes into the clinical considerations in more detail, and our semaglutide information page covers the broader treatment picture.

Wegovy is a prescription-only medicine. Decisions about continuing, pausing or switching dose should always sit with your prescriber, not a forum, not a friend, not a guess. If you have not yet started treatment and want to understand whether it might be right for you, you can check your eligibility with our clinical team, with no obligation.